Dupilumab Improves Lung Function and Reduces Severe Exacerbations in Patients from China with Type 2 Asthma: A Subgroup Analysis of a Phase 3 Randomized Trial

Qingling Zhang, Xiuhua Fu, Haohui Fang, Jie Lin, Arman Altincatal, Yvonne Huang, Jason H Kwah, Olivier Ledanois, Nanshan Zhong

Open source

DOI
10.2147/jaa.s597499
Published
2026-09
Container
Journal of Asthma and Allergy
Publisher
Informa UK Limited
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.2147/jaa.s597499,
  title = {Dupilumab Improves Lung Function and Reduces Severe Exacerbations in Patients from China with Type 2 Asthma: A Subgroup Analysis of a Phase 3 Randomized Trial},
  author = {Qingling Zhang and Xiuhua Fu and Haohui Fang and Jie Lin and Arman Altincatal and Yvonne Huang and Jason H Kwah and Olivier Ledanois and Nanshan Zhong},
  year = {2026},
  journal = {Journal of Asthma and Allergy},
  doi = {10.2147/jaa.s597499},
  url = {https://doi.org/10.2147/jaa.s597499}
}

RIS

TY  - JOUR
TI  - Dupilumab Improves Lung Function and Reduces Severe Exacerbations in Patients from China with Type 2 Asthma: A Subgroup Analysis of a Phase 3 Randomized Trial
AU  - Qingling Zhang
AU  - Xiuhua Fu
AU  - Haohui Fang
AU  - Jie Lin
AU  - Arman Altincatal
AU  - Yvonne Huang
AU  - Jason H Kwah
AU  - Olivier Ledanois
AU  - Nanshan Zhong
PY  - 2026
JO  - Journal of Asthma and Allergy
DO  - 10.2147/jaa.s597499
UR  - https://doi.org/10.2147/jaa.s597499
ER  - 

APA

Zhang, Q., Fu, X., Fang, H., Lin, J., Altincatal, A., Huang, Y., Kwah, J. H., Ledanois, O., & Zhong, N. (2026). Dupilumab Improves Lung Function and Reduces Severe Exacerbations in Patients from China with Type 2 Asthma: A Subgroup Analysis of a Phase 3 Randomized Trial. Journal of Asthma and Allergy. https://doi.org/10.2147/jaa.s597499

Source records